CRISPR’s Nobel Prize sent gene-editing stocks into overdrive

CRISPR’s Nobel Prize sent gene-editing stocks into overdrive

Biotech stocks continued to surge on Wednesday after two scientists responsible for gene-editing tool CRISPR received this year’s Nobel Prize for Chemistry. CRISPR-powered stocks Intellia Therapeutics (NTLA), Editas Medicine (EDIT), and Beam Therapeutics (BEA…

Read More…

Leave a Reply

Your email address will not be published. Required fields are marked *

one + 12 =